Photo from Petros Grivas/X
Jan 29, 2024, 10:40
Petros Grivas: Our phase 2 trial of SG+Pembro in platinum-resistant IO-naive 2L setting
Petros Grivas, Clinical Director of Genitourinary Cancers Program, UW Medicine, shared on X/Twitter:
“Excited for our phase 2 trial of SG+Pembro in platinum-resistant IO-naive 2L setting published Journal of Clinical Oncology ORR 41%, CR 20%, mDOR 11mo (primary endpoint met!) supporting ECOG-ACRIN Cancer Research Group 8231 phase 3 trial launching soon!”
Visit the article website.
Source: Petros Grivas/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 18, 2024, 08:21
Dec 18, 2024, 08:18
Dec 18, 2024, 08:16
Dec 18, 2024, 08:08
Dec 18, 2024, 07:49
Dec 18, 2024, 07:31
Dec 18, 2024, 07:21
Dec 18, 2024, 07:08